Key Studies Influencing My Practice Following Washington 2017
Clinical Impact of New Data From the 2017 Washington, DC, Hepatology Meeting
A Call to Arms: Tools for HCV Treaters to Maximize HCV Cure Rates and Advance Toward HCV Elimination
The Impact of New Options for DAA-Experienced Patients With HCV
Direct-Acting Antiviral Therapy Reduces Mortality in Patients With Decompensated Liver Disease
Disclaimer: The materials published on the Clinical Care Options Sites reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the accredited provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.
Clinical Care Options, LLC. All Rights Reserved.